ESMO WCGIC 2020 | METABEAM: concordance of liquid and tissue biopsies for RAS mutations in CRC

Yoshinori Kagawa, MD, PhD of Kansai Rosai Hospital, Hyogo, Japan, discusses results of the METABEAM study, a combined analysis of concordance studies between liquid and tissue biopsies for RAS mutations in colorectal cancer patients with single metastatic sites. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).